Aurobindo Pharma's Q3 profit surges 19.69% to Rs 712 crore on robust sales
Revenues from operations increased 21.5 percent to 5,269.7 crore during the quarter under review as compared to Rs 4336.1 crore in the year ago period
from Companies http://bit.ly/2Gg3BYs
from Companies http://bit.ly/2Gg3BYs
No comments: